Friday, June 30, 2017


The Complainant, Regeneron Pharmaceuticals, Inc. is a leading science and technology company delivering life-transforming medicines for serious diseases, and owns the REGENERON trademark in Canada (registered since 1998). The Registrant registered the Domain Name in December, 2016 and did not technically respond to the Complaint. The panel found that the Domain Name was registered in bad faith because the Registrant was engaged in a pattern of conduct registering domain names belonging to third party rights holders, had previously lost in an unrelated UDRP proceeding, and in response to this Complaint delivered an email offering to sell the Domain Name to the Complainant in the amount of $1,500.00. 

No comments:

Post a Comment